Literature DB >> 19049421

Heteroleptic dipyrrin/bipyridine complexes of ruthenium(II).

Serena J Smalley1, Mark R Waterland, Shane G Telfer.   

Abstract

The synthesis and characterization of a series of heteroleptic dipyrrinato/2,2'-bipyridine complexes of ruthenium(II) are reported. Spectroscopic analysis, including resonance Raman, indicates that the complexes are only weakly emissive and that the dipyrrin and Ru --> bipyridine (metal-to-ligand charge transfer) chromophores are uncoupled.

Entities:  

Year:  2009        PMID： 19049421     DOI： 10.1021/ic8016497

Source DB:  PubMed          Journal:  Inorg Chem        ISSN： 0020-1669            Impact factor:   5.165


  5 in total

1.  Bis[pyrrolyl Ru(ii)] triads: a new class of photosensitizers for metal-organic photodynamic therapy.

Authors:  Deborah A Smithen; Susan Monro; Mitch Pinto; John Roque; Roberto M Diaz-Rodriguez; Huimin Yin; Colin G Cameron; Alison Thompson; Sherri A McFarland
Journal:  Chem Sci       Date:  2020-10-06       Impact factor: 9.825

2.  Exploiting exciton coupling of ligand radical intervalence charge transfer transitions to tune NIR absorption.

Authors:  Ryan M Clarke; Tiffany Jeen; Serena Rigo; John R Thompson; Loren G Kaake; Fabrice Thomas; Tim Storr
Journal:  Chem Sci       Date:  2017-12-19       Impact factor: 9.825

3.  Asymmetric ruthenium(II) and osmium(II) complexes with new bidentate polyquinoline ligands. Synthesis and NMR characterization.

Authors:  Antonino Mamo; Alessandro Aureliano; Antonino Recca
Journal:  Molecules       Date:  2010-03-05       Impact factor: 4.411

4.  Manipulating Metallogel Properties by Luminogens and Their Applications in Cell Imaging.

Authors:  Arnab Biswas; Sujay Mukhopadhyay; Roop Shikha Singh; Ashish Kumar; Nishant Kumar Rana; Biplob Koch; Daya Shankar Pandey
Journal:  ACS Omega       Date:  2018-05-21

5.  Facile deprotection of F-BODIPYs using methylboronic acid.

Authors:  Craig D Smith; Alison Thompson
Journal:  RSC Adv       Date:  2020-06-25       Impact factor: 4.036
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.